SCHEMBL2721422

SCHEMBL2721422

O=C(COc1ccc2c(c1)OCCO2)N(Cc1cccs1)c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ TRPM8 Q7Z2W7 12/20 0.67
▸ TP53 P04637 5/20 0.58
▸ LMNA P02545 4/20 0.54
▸ THRB P10828 1/20 0.54
▸ TDP1 Q9NUW8 1/20 0.53
▸ POLB P06746 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31647347 1.00 TRPM8 (0.67) TRPM8TP53LMNATHRBTDP1
SCHEMBL2729280 0.94 TRPM8 (0.70) TRPM8TP53LMNATHRBTDP1
SCHEMBL23126358 0.86 MAOB (0.55) TRPM8LMNAPOLB
SCHEMBL2717391 0.83 TRPM8 (0.84) TRPM8TP53LMNATHRBTDP1
SCHEMBL6408147 0.83 TRPM8 (0.72) TRPM8TP53LMNATHRBTDP1
SCHEMBL2729893 0.82 TRPM8 (0.70) TRPM8TP53LMNATHRBTDP1
SCHEMBL2716916 0.82 TRPM8 (0.78) TRPM8TP53LMNATHRBTDP1
SCHEMBL30582860 0.82 TRPM8 (0.78) TRPM8TP53LMNATHRBTDP1
SCHEMBL2730206 0.81 TRPM8 (0.70) TRPM8TP53LMNATHRBTDP1
SCHEMBL30582854 0.81 TRPM8 (0.70) TRPM8TP53LMNATHRBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109414048-B Coated yeast formulation 弗门尼舍有限公司 2023-09-01 — — CN disclosed
US-11234450-B2 Preparations having a cooling effect SYMRISE AG (DE) 2022-02-01 — — US disclosed
US-11091734-B2 Plated yeast formulations FIRMENICH SA (CH) 2021-08-17 — — US disclosed
US-10953007-B2 Compounds useful as modulators of TRPM8 FIRMENICH INCORPORATED (US) 2021-03-23 — — US disclosed
EP-3470407-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2019-04-17 — — EP disclosed
US-10182584-B2 Cooling preparations SYMRISE AG (DE) 2019-01-22 — — US disclosed
US-10016418-B2 Compounds useful as modulators of TRPM8 Seaomyx, Inc. (US) 2018-07-10 — — US disclosed
US-10016418-B2 Compounds useful as modulators of TRPM8 Seaomyx, Inc. (US) 2018-07-10 — — US disclosed
US-20180055069-A1 PREPARATIONS SYMRISE AG (DE) 2018-03-01 — — US disclosed
US-20180055069-A1 PREPARATIONS SYMRISE AG (DE) 2018-03-01 — — US disclosed
US-20160317532-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED 2016-11-03 — — US disclosed
US-9394287-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2016-07-19 — — US disclosed
US-9394287-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2016-07-19 — — US disclosed
US-20150313820-A1 PREPARATIONS SYMRISE AG (DE) 2015-11-05 — — US disclosed
US-20150313820-A1 PREPARATIONS SYMRISE AG (DE) 2015-11-05 — — US disclosed
EP-2635572-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2013-09-11 — — EP disclosed
WO-2012061698-A9 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2012-09-13 — — WO disclosed
WO-2012061698-A9 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2012-09-13 — — WO disclosed
WO-2012061698-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2012-05-10 — — WO disclosed
WO-2012061698-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2012-05-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10953007-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPM6 TRPM8 1/4885TP53 4485/4885LMNA 4155/4885
US-11234450-B2 Preparations having a cooling effect CRAT, CPT2, CPT1A TRPM8 60/4885TP53 3181/4885LMNA 1034/4885
US-10016418-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPM6 TRPM8 1/4885TP53 4485/4885LMNA 4155/4885
US-20160317532-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM7, TRPM6 TRPM8 1/4885TP53 4485/4885LMNA 4155/4885
US-10182584-B2 Cooling preparations CRAT, ACAT2, TAS2R50 TRPM8 62/4885TP53 3036/4885LMNA 1453/4885
US-20180055069-A1 PREPARATIONS CRAT, ACAT2, TAS2R50 TRPM8 101/4885TP53 2706/4885LMNA 1435/4885
US-20150313820-A1 PREPARATIONS CRAT, ACAT2, TAS2R50 TRPM8 101/4885TP53 2706/4885LMNA 1435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback